Mediation of the schistosomicidal effect of praziquantel through nitric oxide

Arzneimittel-Forschung/Drug Research

Volumn 52, Issue 11, 2002, Pages 844-848

  Ammar, Elsayed M ^a   Said, Shehta A ^a   Eissa, Laila A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

CAS 55268 74 1; L Arginine; Nitric oxide; Praziquantel; Schistosoma mansoni

Indexed keywords

ANTISCHISTOSOMAL AGENT; ARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PRAZIQUANTEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; MOUSE; NONHUMAN; OXIDATIVE STRESS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; WORM INFECTION;

EID: 0036437829     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1299978     Document Type: Article

References (17)

1. WHO: The control of schistosomasis. Second report of WHO expert committee. WHO Tech. Rep. Ser. 830 (1993)
2. Day, T. A., Bennett, J. L., Pax, R. A., Praziquantel: The enigmatic antiparasitic. Parasitol. Today 8, 342 (1992)
3. Metwally, A. A., Bennett, J., Botros, S. et al., Impact of drug dosage and brand on bioavailability and efficacy of praziquantel. Pharmacol. Res. 31, 53 (1995)
4. Mahmoud, A. A. F., Praziquantel for the treatment of helmenthic infections. Adv. Intern. Med. 32, 193 (1987)
5. Xiao, S., Catto, B. A., Webster, L. T. Jr., Effect of praziquantel on different stages of Schistosoma mansoni in-vivo and invitro. J. Infect. Dis. 151, 1130 (1985)
6. Harmestt, W., Kusel, J. R., Increased exposure of parasitic antigens at the surface of adult male Schistosoma mansoni exposed to praziquantel in-vitro. J. Parasitol. 93, 401 (1986)
7. Fostermann, N. A., Schmidt, H. H., Pollock, J. S. et al., Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem. Pharmacol. 42, 1849 (1991)
8. Tracey, W. R., Tse, J., Carter, G., Lipopolysaccharide-induced changes in plasma nitrate and nitrite concentrations in rats and mice. Pharmacological evaluation of nitric oxide synthase inhibitors. J. Pharmacol. Exp. Ther. 272, 1011 (1995)
9. Evans, T. G., Thai, L., Granger, D. L. et al., Effect of in-vivo inhibition of nitric oxide production in murine leishmaniasis. J. Immunol. 151, 907 (1993)
10. Nathan, C., Nitric oxide as a secretory product of mammalian cells. FASEB 6, 3051 (1992)
11. Mac-Micking, J. D., Dcie, Q. W., Nathan, C., NO and macrophages function. Ann. Rev. Immunol. 15, 323 (1997)
12. Standen, O. D., Experimental schistosomiasis: III: Chemotherapy and mode of drug action. Ann. Trop. Med. Parasitol. 47, 26 (1953)
13. Schmidt, H. H., Warner, T. D, Nakane, M. et al., Regulation and subcellular location of nitrogen oxide synthase in RAW 264.7 macrophages Mol. Pharmacol. 41, 615 (1992)
14. Liew, F. Y., Millott, S., Parkinson, C. et al., In-vivo is mediated by nitric oxide from L-arginine J. Immunol. 144, 4794 (1990)
15. Silva, J. S., Vespa, G. N., Cardosa, et al., Tumor necrosis factor alpha mediates resistance to T. cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect. Immun. 63, 4862 (1995)
16. Oswald, I. P., Eltoun, I., Wynn, T. A. et al., Schishtosoma mansoni through the production of nitric oxide. J. Proc. Natl. Acad. Sci USA 91, 999 (1994)
17. Lemesreine, J. L., Sereno, D., Daulouduićde, S. et al., Leshmania spp: Nitric oxide-mediated metabolic inhibition of promastigote and asexually grown amastigote forms. Exp. Parasitol. 86, 58 (1997)